Covidien has announced the launch of its Nellcor SpO2 single parameter module for use with the Philips IntelliVue patient monitoring platform, according to a news release. The Nellcor SpO2 module ...
Medtronic plc MDT recently announced favourable outcome of an independent prospective observational study, which was published online in the Journal of Perinatology. This study compared the efficacy ...
“Clinicians can feel confident using the Nellcor Portable SpO 2 Patient Monitoring System for these important patient assesments,” said Dr. Scott Kelley, chief medical officer, Respiratory and ...
<0> CovidienRhonda Luniak, 303-305-2263Vice PresidentR&MS CommunicationsorBruce Farmer, 508-452-4372Vice PresidentPublic RelationsorColeman Lannum, CFA, 508-452-4343Vice PresidentInvestor ...
DUBLIN, Ireland--(BUSINESS WIRE)-- Covidien (NYSE: COV) today announced CE Mark approval for its Nellcor™ Bedside SpO 2 Patient Monitoring System, PM100N. The system currently is available in the ...
BOULDER, Colo.--(BUSINESS WIRE)--Every year, nearly 7,200 infants are born in the United States with a Critical Congenital Heart Disease (CCHD). 1 It is a condition that is often easily detectable and ...
DUBLIN, Feb. 9, 2021 /CNW/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the results of an independent, prospective observational study comparing the efficacy ...
Covidien Receives FDA 510(k) Clearance for Nellcor™ Pulse Oximetry Motion Claims Nellcor pulse oximeters only FDA 510(k)-cleared oximeters compliant with ISO 80601-2-61 BOULDER, Colo.--(BUSINESS WIRE) ...
BOULDER, Colo.--(BUSINESS WIRE)-- Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in mechanical ventilation and respiratory care devices, today ...
Medtronic plc MDT recently announced favourable outcome of an independent prospective observational study, which was published online in the Journal of Perinatology. This study compared the efficacy ...
Covidien (NYSE: COV) today announced CE Mark approval for its Nellcor™ Bedside SpO 2 Patient Monitoring System, PM100N. The system currently is available in the European Economic Area (EEA), Australia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback